Cart
sales@molnova.com
PQR514
CAS No. 1927857-55-3
PQR514( —— )
Catalog No. M36324 CAS No. 1927857-55-3
PQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 506 | Get Quote |
|
| 5MG | 751 | Get Quote |
|
| 10MG | 1064 | Get Quote |
|
| 25MG | 1536 | Get Quote |
|
| 50MG | 2006 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePQR514
-
NoteResearch use only, not for human use.
-
Brief DescriptionPQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
-
DescriptionPQR514 is a potent PI3K inhibitor with anticancer activity and inhibits cancer cell proliferation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1927857-55-3
-
Formula Weight394.38
-
Molecular FormulaC16H20F2N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)C1=NC(=NC=C1C2=NC(=NC(=N2)N3CCOCC3)N4CCOCC4)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MLN1117
MLN1117 (INK1117,TAK-117, Serabelisib) is a potent, selective PI3K p110α inhibitor with IC50 of 15 nM.
-
CZC24832
CZC24832 is a selective inhibitor of PI 3-kinase γ (IC50 = 1.0 μM in a PI 3-Kγ-dependent fMLP-induced neutrophil migration assay).
-
PQR309
PQR309 (Bimiralisib) is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50 of 33, 451, 661, 708 and 89 nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively.
